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Abstract A unifying theme common to the action of many
cationic peptides that display lethal activities against
microbial pathogens is their specific action at microbial
membranes that results in selective loss of ions and small
nucleotides—chiefly ATP. One model cationic peptide that
induces non-lytic release of ATP from the fungal pathogen
Candida albicans is salivary histatin 5 (Hst 5). The major
characteristic of Hst 5-induced ATP release is that it occurs
rapidly while cells are still metabolically active and have
polarized membranes, thus precluding cell lysis as the
means of release of ATP. Other cationic peptides that
induce selective release of ATP from target microbes are
lactoferricin, human neutrophil defensins, bactenecin, and
cathelicidin peptides. The role of released extracellular ATP
induced by cationic peptides is not known, but localized
increases in extracellular ATP concentration may serve to
potentiate cell killing, facilitate further peptide uptake, or
function as an additional signal to activate the host innate
immune system at the site of infection.
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Introduction
Microbes come in contact with naturally occurring cationic
proteins from many sources [1]. Fluids and mucosal
surfaces in the oral cavity, lacrimal fluids, and gut are all
rich in peptides that limit the colonization and overgrowth
of indigenous bacteria and fungi. Their protective functions
become evident upon loss of these peptides, which often
results in dramatic bacterial and fungal overgrowth. Thus,
conditions that reduce salivary flow in the oral cavity
predispose host tissues to candidiasis and increased bacteria
colonization [2].
Understanding the mechanism by which these cation
peptides limit microbial growth is important not only
because of the crucial role that these innate peptides play
in human health, but also because of the possibility of
therapeutic use of naturally occurring peptides [3, 4].
Therefore, the mechanism by which host-derived peptides
distinguish bacterial and fungal targets from self is a
fundamental question. In addition, the discrimination
mechanism by which these peptides exert lethal effects on
microbes, but not on host tissues, is central to their potential
use as alternative or complementary drug therapies. One
unifying theme that is common to many peptides that
display lethal activities against microbial pathogens is their
specific action at microbial membranes that results in
selective loss of ions and small nucleotides—chiefly ATP.
The commonality of this mode of action and the signifi-
cance of selective ATP release are themes discussed in this
review.
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Cytoplasmic membrane dysfunction through pore forma-
tion appears to be a common mechanism of action of many
antimicrobial peptides active against bacteria [5–7]. Pep-
tides initially bind with the target microbe membrane via
electrostatic interactions with the negatively charged sur-
face or by binding with lipopolysaccharides (LPS) in the
bacterial outer membrane. After binding of peptide mono-
mers has occurred, the peptide is inserted into membranes,
followed by self-association and formation of localized
aggregates, and culminating in formation of membrane
pores. Peptide-induced pores allow release of ATP, ions,
and other molecules, membrane depolarization, osmotic
dysregulation, and ultimately cell death. Examples of such
mechanisms of killing between peptides and their mem-
brane targets include magainin 2 in gram-negative bacteria
[8], thrombin-induced platelet microbicidal protein [9], and
human defensins and lactoferrin [10, 11].
An alternative mechanism to nonspecific pore formation
as a route to release ATP from cells is peptide association
with specific proteins within target cell membranes that
results in loss of function of the membrane protein. Such
interactions confer specificity of the peptide for a vulner-
able cell. Many naturally occurring toxins exert their effects
through inhibition of sodium or potassium ion channel
functions [12, 13]. These small peptides (22–60 amino acid
residues) are the venoms produced by diverse animal
species such as scorpions, snakes, spiders, and sea anem-
ones. Such toxins blockade ion channels, either by direct
occlusion of the pore or by causing allosteric modification
to the channel. Other toxins may indirectly affect channel
function by alteration of other channel-interacting mole-
cules such as enzymes [14]. In either case, the result is loss
of the cellular ion gradient, which in turn causes membrane
depolarization or inactivation of potassium-dependent
enzymes and pathways. In order to recover and stabilize
the membrane potential, the cell compensates by activating
other membrane proteins, such as ATP hydrolyzing pumps
or channel-mediated transport of Na
+ and Cl
−, and thus
requires utilization of cellular energy [15].
Cationic peptides induce ATP release integral
to microbicidal activity
Histatins
In terms of mechanism of antimicrobial activity, perhaps
one of the best studied cationic peptides causing non-lytic
release of ATP is the salivary histatin 5 (Hst 5). Histatin 5
first binds to Candida albicans cell wall proteins [16],
identified as Ssa1/2 proteins from the heat shock 70 family
[17], which facilitate intracellular transport to other effector
sites for its toxic activity. Hst 5 binding, translocation, and
toxicity are closely related processes, and loss of either
Ssa1 or Ssa2 proteins results in diminished Hst 5 intra-
cellular transport and cell killing [17]. Similarly, internal-
ization of histatin variant peptides dhvar4 and dhvar5 has
been demonstrated [18, 19], but it is not clear whether they
also require binding to ssa1/2p on the fungal cell envelope
for their activity. A specific binding site for Hst 5 has been
identified on Porphyromonas gingivalis as well, showing
that the antimicrobial activity of Hst 5 may be mediated by
binding to specific receptor(s) on the cell surface [20].
One of the most prominent features of salivary histatins
and variant peptides killing of C. albicans is the rapid
efflux of cellular ATP and other small nucleotides such as
NAD
+,A M P ,A D P ,a n di o n s ,a sw e l la sc o n c u r r e n t
intracellular uptake of the DNA-binding dye propidium
iodide [19, 21, 22]. Histatin-induced ATP release does not
require extracellular binding, since these effects can be
initiated solely from intracellular sites [23]. ATP efflux and
depletion of intracellular ATP in C. albicans cells following
Hst 5 treatment has been shown to be concentration and
time dependent, with maximal depletion of about 85% of
intracellular ATP occurring within 30 min of exposure to
physiological concentrations of Hst 5 [21]. The major
characteristic of Hst 5-induced ATP release was that it
occurred while C. albicans cells were metabolically active
and had polarized membranes, thus precluding cell lysis as
a possible route by which ATP was released from the cells
[21]. Interestingly, Hst 5 killing of anaerobic cultures was
reduced compared to cells grown under air, although
incubation of anaerobically grown cells with Hst 5 caused
a marked increase in extracellular ATP (ATPe) and a
drastic depletion of cellular ATP compared to the
untreated cells [21]. Pretreatment of C. albicans cells with
ion transport inhibitors, such as 4,4′-diisothiocyanlstil-
bene-2, 2′- d i s u l f o n i ca c i d( D I D S ) ,a n dn i f l u m i ca c i da l l
blocked ATP loss and killing in Hst 5-treated C. albicans,
suggesting that Hst 5 activity is mediated by ion
transporter(s) on yeast plasma membrane [24]. Indeed,
deletion of TRK1, the major plasma membrane K
+ uptake
system in C. albicans, nearly abolished Hst 5-initiated
ATP release, cell killing, and cellular permeability for
propidium iodide [25, 26, 27], indicating that Hst 5
ultimately results in alteration of Trk1p function. The
current model for Hst 5 activity, which may be similar to
other cationic peptides, is shown in Fig. 1.
Whether the ATPe released from C. albicans in response
to Hst 5 might have a further physiological role in cell
death is not clear. Previously we suggested that ATP
released from C. albicans by Hst 5 may auto-activate
membrane receptors to cause cell death, although we have
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in C. albicans cells [21]. In higher eukaryotic cells, released
purine nucleotides and nucleosides interact with cell surface
receptors (purinoreceptors) to induce a range of biological
effects including cytotoxicity [28]. In this regard, applica-
tion of the peptide antibiotic polymyxin B to immune cells
synergized plasma membrane permeabilization induced by
ATP, so that cell killing was enhanced by the combined
application of both ATP and polymyxin B [29]. For fungal
cells, treatment of C. albicans cells for 3 h with high doses
of P2X7-selective ATP analogues BzATP, ATPγS, and
ATP
4− caused about a 60% loss of viability of aerobically
grown cells, suggesting that ATPe itself may potentiate cell
killing [21]. Pretreatment of C. albicans cells with the
phosphatase apyrase (an ATP-consuming enzyme) greatly
reduced Hst 5-induced cell death [21], further supporting
the requirement for available ATPe in Hst 5 activity. In the
case of Hst 5-treated cells, released ATP may act upon cells
already severely depleted of ATP, so that cells may be more
prone to ATP-mediated killing in a synergistic manner with
Hst 5. Alternatively, Hst 5 entry into the cells may itself
require ATP. In this respect, ATP might facilitate Hst 5
binding to ssa1/2p on the cell envelope, since heat shock
proteins function in a strongly ATP-dependent manner [30].
Whether Ssa proteins utilize intracellular and/or ATPe for
Hst 5 binding and translocation has not been demonstrated,
but since inhibition of mitochondrial ATP synthesis pro-
tected C. albicans from the fungicidal activity of histatin 5
and this protection appeared to be due to reduced cellular
accumulation of the peptide [31], such a possibility should
be considered.
Lactoferrin and derived peptides
Lactoferrin is an abundant 77-kDa iron-binding glycopro-
tein found in saliva. The iron-binding domain of the
lactoferrin molecule is located at the carboxy terminus,
while the highly basic N-terminal region contains a 25-
amino-acid microbicidal domain termed lactoferricin (LF).
The N-terminus of LF, LF(1–11) consisting of only 11
amino acid residues, retains complete bactericidal and
antifungal properties [32].
LF(1–11) appears to have similar features in its
antifungal activity to histatin 5, in that it induces extracel-
lular release of ATP and other nucleotides and ions [33],
and subsequent loss of viability occurs in an energy-
dependent manner [32]. These effects were not related to
extensive membrane permeabilization [34] since LF did not
cause release of macromolecular cytosolic constituents and
was unable to disrupt the liposomal phospholipid bilayer in
vitro [35]. In addition, LF was internalized prior to cell
death [36], thus indicating that LF affects cytoplasmic
targets rather than forming pores in plasma membrane of
susceptible fungi.
Like Hst 5, LF(1–11) caused a time- and dose-
dependent increase in ATPe, which was completely blocked
by pretreatment of cells with azide [32]. ATPe seems to
play a role in the killing of Candida cells following
treatment with peptides derived from the N-terminus of
human lactoferrin, since preincubation with oATP, which
irreversibly blocks the interaction between ATPe and
extracellular receptors, resulted in significant protection
from killing [37]. However, addition of ATP or ATP
analogues (such as BzATP and ATPγS) was not sufficient
to kill C. albicans, nor did ATP act synergistically with LF
peptide to induce C. albicans cell death [32, 37].
Despite the striking similarities to the Hst 5 mechanism
of antifungal action, lactoferricin killing of C. albicans has
unique steps as well. In this respect, C. albicans spheroplast
susceptibility to human LF was significantly reduced
following treatment with proteinase K [33], thus suggesting
the possibility that LF-induced killing is mediated by
specific protein receptor(s) on the cell surface. However,
our results showed that C. albicans susceptibility to LF(1–
11) was not altered in SSA mutant strains [27], thus
suggesting that the Hst 5 Candida cell wall binding protein
ssa1/2p is not a binding site for LF.
Fig. 1 Mechanism of action of histatin 5 with target Candida
albicans cells
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to LF peptides compared to wild-type cells. As for Hst 5,
TRK1 knockdown strains were protected from cell death
and concurrent propidium iodide uptake induced by LF
[27]. Although we did not quantify the effect of LF on
ATPe release in TRK1-deficient cells, ATP release corre-
lates with the percentage of PI-positive cells as previously
reported [32]. Similarly to the effect of salivary Hst 5, LF
treatment of C. albicans cells seems to involve transporter-
mediated efflux of intracellular ATP and ions, which
contributes to cell death [38]. Thus, LF may modulate the
function of Candida cell membrane transporters, and
possibly other proteins maintaining membrane integrity. In
this context, the synthetic D-decapeptide BM2 (D-NH2-
RRRFWWFRRR-CONH2), which shares the first nine
residues of LF(1–11), acts as a specific inhibitor of the
yeast plasma membrane ATP-driven proton pump Pma1p
[39]. However, we found that LF(1–11)-induced killing of
PMA1 knockdown strains was undistinguishable from that
of wild-type cells (unpublished data), thus indicating that
LF(1–11) does not exert its effects by affecting Pma1p
function.
Bactenecins
Bactenecins are proline-rich peptides processed from
precursor cathelicidins, residing with other antimicrobial
peptides in large granules within polymorphonuclear
neutrophils. Bactenecins are active against gram-positive,
gram-negative bacteria and fungi. Similar to antibacterial
activity of LF, bactenecin and derived peptides have been
shown to bind electrostatically to negatively charged LPS
molecules of the outer membrane of bacteria [40], then
enter the cytoplasm and inhibit multiple intracellular targets
[40, 41]. Although the exact intracellular targets for
bactenecin action have not been identified, we found that
TRK1 potassium transporter-deficient C. albicans cells had
reduced susceptibility to bactenecin compared with wild-
type cells, indicating that ion transporters may be possible
cytoplasmic-localized effectors involved in the killing
mechanism of fungi [27].
Human neutrophil defensins
Mammalian defensins are a family of cationic peptides that
are divided into α- and β-defensin subfamilies on the basis
of the connectivity of highly conserved cysteine residues.
Human neutrophil defensins (HNP-1 to HNP-4) are stored
in azurophilic granules of the neutrophil. They are
transferred to phagolysosomes upon phagocytosis to kill
ingested microbes. However, these peptides can also be
released into the extracellular space, where they not only
contribute to extracellular killing of microorganisms but
also can recruit neutrophils, memory T cells, and immature
dendritic cells to the site of infection. Human β-defensins
(HBD-1 through HBD-4), expressed predominantly in
epithelial cells of mucous membranes and in keratinocytes,
are well studied in terms of active concentrations and
spectrum of antimicrobial activity, but very little is known
about their mechanism of action.
The precise mechanism for antibacterial activity of
human neutrophil defensins has not yet been clearly
defined, but it has been widely believed that defensins
permeabilize membranes through multimeric pore forma-
tion [42]. It has been suggested that the cationic character-
istic and amphipathic nature of antimicrobial peptides
allows binding to and direct interaction with the lipid
bilayer of cell membrane, leading to leakage of the internal
aqueous content of the cell. Defensins contain β-sheet
structures, a feature that enables formation of ion channels
in model lipid membranes [43]. The presumed mechanism
for their action includes (1) binding to anionic groups
located outside of the bacterial membrane, (2) insertion into
the membrane to form aggregates, and (3) finally produce
an assembly of six or more dimers to form a pore as it was
shown with Staphylococcus aureus [44]. Studies of α-
defensins did not reveal specificity toward a distinct target
membrane, since they were active against bacteria, envel-
oped viruses, and fungi. However, defensins are able to
discriminate between bacterial membranes and membranes
of higher eukaryotic organisms by preferential interaction
with anionic phospholipids that are predominant in pro-
karyotic cells [44].
The antifungal mechanism of action of defensins differs
greatly from the nonspecific membrane permeabilization
found against bacteria. HNP-1 induced a dose-dependent
efflux of ATP from C. albicans cells that was inhibited by
the same pharmacological agents (CCCP, DNP, and azide)
and ionic conditions (Ca
2+ and Mg
2+) found to inhibit Hst 5
killing of C. albicans [45]. HNP-1-induced efflux of
cellular ATP occurred while cells were respiring and had
polarized membranes, showing that membrane disruption
was not the cause of selective loss of nucleotide [45].
Similarly, incubation of C. albicans cells with lethal doses
of HBD-2 or HBD-3 did not result in loss of membrane
integrity [46].
Cathelicidin peptides and LL37
LL37 belongs to the cathelicidins family, a group of
proteins that are characterized by a highly conserved
cathelin pro-sequence linked to a variable antimicrobial
domain [47]. In C. albicans, the localization of LL37 was
confined mainly to the cell perimeter in a pattern very
similar to cells treated with Calcofluor White M2R (a
specific cell wall marker), suggesting an association with
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treatment of these cells with the peptide caused a complete
disappearance of the integrity of cellular membranes,
resulting in leakage of ATP and other small nucleotides,
but without loss of proteins larger than 40 kDa [47].
The ability of LL37 to cause membrane perforation of
the membrane in Actinobacillus actinomycetemcomitans
[48] and other gram-negative bacteria has been shown to be
dependent on more negatively charged cell membranes,
compared with strains having lower zeta potential values
[48]. Disintegration of the outer and inner membrane of A.
actinomycetemcomitans resulted in cell membrane perfora-
tion, suggesting that the target of LL37 is the bacterial
membrane and LPS. In this regard, it has been reported that
Treponema denticola showed resistance to antimicrobial
peptides due to the lack of LPS [48]. These results
suggested that the strains with a highly negative charge
are more susceptible to antimicrobial peptides among the
same bacterial species as shown for A. actinomycetemco-
mitans and S. aureus [48, 49]. Interestingly, LL37 itself
may be able to stimulate immune cells, since application of
LL37 to LPS-primed monocytes induced a transient release
of ATP and interleukin (IL)-1 beta release via the P2X(7)
receptor without cell cytotoxicity [50] (Table 1).
Temporins, dermaseptins, and nisin
Other small cationic peptides that act upon pathogenic
bacteria and fungi show similar patterns of membrane
permeabilization and loss of intracellular ATP. However,
this group of peptides appears to have more significant
species-dependant membrane effects that include loss of
larger intracellular molecules in addition to ATP.
Temporins are a family of linear 10–13 residue cationic
peptides isolated from the skin of the European red frog
Rana temporaria that are active against gram-positive
bacteria and C. albicans. The reported mechanism of
antimicrobial action against Leishmania includes rapid
induction membrane potential collapse as well as lowering
the intracellular ATP levels [51]. Temporins induce perme-
ation of the membrane (characterized by alteration of the
K
+ and Na
+ gradient across the membrane and influx of
vital dyes such as the SYTOX Green) simultaneously with
inhibition of parasite proliferation [51].
Dermaseptin S3 has been shown to exert antimicrobial
action by specific interactions of the amphipathic α-helix
moiety with the plasma membrane phospholipids, leading
to cell permeabilization [52]. Studies on Saccharomyces
cerevisiae have shown that exposure to the peptide results
in significant loss of ADP and ATP and other UV-absorbing
compounds into the surrounding medium and that this
efflux was significantly increased at, or near, a neutral pH.
Upon exposure to dermaseptin, the majority of cells were
rapidly permeabilized [53].
Nisin acts against Listeria monocytogenes in a combi-
nation of effects due to membrane disruption, such as
depolarization and inhibition of the respiratory chain and
the loss of critical cellular components such as ATP and
intracellular K
+ ions to the external environment [54].
Role of ATPe on host immune response and microbial
clearance Since a prominent feature of nearly all cationic
peptides upon interaction with target microbes is the loss of
ATP into the extracellular media, it has been proposed that
such localized increases in ATP levels results in potent
immunomodulatory activities, such as chemoattraction of
human monocytes, T cells and mast cells, and induction of
chemokines [55, 56]. Thus, peptide-induced ATP release
from microbial pathogens not only serves to disable
targeted cells, but may also be an important signal for the
host immune response. The ability of innate defense pep-
tides, chiefly defensins and cathelicidins, to contribute to
stimulation of immune responses has prompted them to be
reclassified as “alarmins” in recognition of their immuno-
modulatory role [57]. It is possible that peptide-induced
loss of ATP at the site of infection may serve as an addi-
tional signal to activate the innate immune system [58, 59].
Thus, antimicrobial peptides may possess biological func-
tions extending beyond the innate immune response, perhaps
synergizing with ATPe in stimulating immune response.
Conclusions One of the unifying signatures following
interactions of cationic peptide agents with target microbial
cells is the rapid release of intracellular nucleotides,
especially ATP, into the surrounding environment. A long-
held paradigm for the microbicidal action of cationic
peptides is that killing of target microbial cell membranes
occurs chiefly as a result of creation of membrane pores in
the organism, leading to leakage of ions and metabolites.
While it is likely that these effects contribute to ultimate
microbial cell death, a mounting body of evidence supports
additional or complementary mechanisms, so that mem-
brane permeabilization alone appears insufficient to cause
cell death. Rather, depletion of intracellular ATP and loss of
ion balance are likely to have metabolic effects that cause







Histatin 5 Yes No Yes
Lactoferricin Yes No Yes
Bactenecin ND ND Yes
HNP-1 Yes ND Yes
Cathelicidin Yes Yes ND
Purinergic Signalling (2007) 3:91–97 95cell cycle arrest rather than immediate cell death. A
localized increase in eATP at the site of contact of cationic
peptides with infecting microorganisms may itself be a
significant signal for host immune enhancement to promote
eradication of pathogenic microbes.
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